BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi T, Wu L, Ma W, Ju L, Bai M, Chen X, Liu S, Yang X, Shi J. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine. Evid Based Complement Alternat Med 2020;2020:8749564. [PMID: 31998400 DOI: 10.1155/2020/8749564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Moravej SAA, Shojaii A, Hashem Dabaghian F, Jazayeri SF, Moravej SZ, Khadem E, Agah S, Ghods R. The Efficacy of Rosa damascena on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. Evid Based Complement Alternat Med 2021;2021:6628911. [PMID: 34422077 DOI: 10.1155/2021/6628911] [Reference Citation Analysis]
2 Sztolsztener K, Chabowski A, Harasim-Symbor E, Bielawiec P, Konstantynowicz-Nowicka K. Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development. Biomolecules 2020;10:E1133. [PMID: 32751983 DOI: 10.3390/biom10081133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lin S, Zhao X, Sun Y, Liu H, Shang M, Gong J, Ma Q, Piao G, Yuan H. Inhibitory effects of compounds from the roots of Potentilla longifolia on lipid accumulation. PLoS One 2020;15:e0238917. [PMID: 32903285 DOI: 10.1371/journal.pone.0238917] [Reference Citation Analysis]
4 Li H, Chen H, Shi W, Shi J, Yuan J, Duan C, Fan Q, Liu Y. A novel use for an old drug: resistance reversal in Candida albicans by combining dihydroartemisinin with fluconazole. Future Microbiol 2021;16:461-9. [PMID: 33960815 DOI: 10.2217/fmb-2020-0148] [Reference Citation Analysis]
5 Dai X, Feng J, Chen Y, Huang S, Shi X, Liu X, Sun Y. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chin Med 2021;16:68. [PMID: 34344394 DOI: 10.1186/s13020-021-00469-4] [Reference Citation Analysis]
6 Hu Q, Wei S, Wen J, Zhang W, Jiang Y, Qu C, Xiang J, Zhao Y, Peng X, Ma X. Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease. BioData Min 2020;13:11. [PMID: 32863886 DOI: 10.1186/s13040-020-00224-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Li H, Liu NN, Peng ZG. Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis. BMJ Open 2020;10:e039700. [PMID: 33277283 DOI: 10.1136/bmjopen-2020-039700] [Reference Citation Analysis]
8 Ying Y, Zhang H, Yu D, Zhang W, Zhou D, Liu S. Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis. Evid Based Complement Alternat Med 2021;2021:6659445. [PMID: 33643422 DOI: 10.1155/2021/6659445] [Reference Citation Analysis]
9 Ore A, Akinloye OA, Adeogun AI, Ugbaja RN, Morifi E, Makatini M, Moepya R, Mbhele T. Buchholzia coriacea seed (wonderful kolanut) alleviates insulin resistance, steatosis, inflammation and oxidative stress in high fat diet model of fatty liver disease. J Food Biochem 2021;:e13836. [PMID: 34184286 DOI: 10.1111/jfbc.13836] [Reference Citation Analysis]
10 Zhang J, Du H, Shen M, Zhao Z, Ye X. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. J Immunol Res 2020;2020:3413186. [PMID: 32884949 DOI: 10.1155/2020/3413186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang S, Wong YT, Tang KY, Kwan HY, Su T. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science. Front Endocrinol (Lausanne) 2020;11:572729. [PMID: 33101207 DOI: 10.3389/fendo.2020.572729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Tang R, Li R, Li H, Ma XL, Du P, Yu XY, Ren L, Wang LL, Zheng WS. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. ACS Nano 2021. [PMID: 34705426 DOI: 10.1021/acsnano.1c02158] [Reference Citation Analysis]
13 Yin K, Zhou X, Jiang W, Wang L, Dai Z, Tang B. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease. Dis Markers 2021;2021:9963534. [PMID: 34239622 DOI: 10.1155/2021/9963534] [Reference Citation Analysis]
14 Sachinvala ND, Teramoto N, Stergiou A. Proposed Neuroimmune Roles of Dimethyl Fumarate, Bupropion, S-Adenosylmethionine, and Vitamin D3 in Affording a Chronically Ill Patient Sustained Relief from Inflammation and Major Depression. Brain Sci 2020;10:E600. [PMID: 32878267 DOI: 10.3390/brainsci10090600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jazayeri SF, Ghods R, Hashem Dabaghian F, Shojaii A, Moravej SAA, Khadem E, Seyedian SS. The Efficacy of Plantago major Seed on Liver Enzymes in Nonalcoholic Fatty Liver Disease: A Randomized Double-Blind Clinical Trial. Evid Based Complement Alternat Med 2021;2021:6693887. [PMID: 33854559 DOI: 10.1155/2021/6693887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liang XY, Hong FF, Yang SL. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes 2021;14:1871-83. [PMID: 33953586 DOI: 10.2147/DMSO.S304817] [Reference Citation Analysis]